1.89
price down icon1.05%   -0.02
after-market Dopo l'orario di chiusura: 1.96 0.07 +3.70%
loading

Inmune Bio Inc Azioni (INMB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
0.05 - - -
Operating Expenses
146.82%
24.57
9.955 9.467 12.29 9.865
Benefits Costs and Expenses
-
- -42.07 - -
Costs And Expenses
146.82%
24.57
9.955 -75.25 12.29 9.865
Operating Income/Loss
148.07%
-24.57
-9.905 -9.467 -12.29 -9.865
Nonoperating Income/Loss
31.93%
0.113
0.166 0.249 0.193 -
Income/Loss From Continuing Operations Before Tax
151.13%
-24.46
-9.739 42.07 -12.09 -9.746
Income/Loss From Continuing Operations After Tax
151.13%
-24.46
-9.739 74.95 -12.09 -9.746
Net Income/Loss
151.13%
-24.46
-9.739 -9.218 -12.09 -9.746
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.57%
23.30
22.50 0.7675 20.19 19.31
Diluted Average Shares
3.57%
23.30
22.50 0.7675 20.19 19.31
Basic Earnings Per Share
144.19%
-1.05
-0.43 -0.40 -0.60 -0.50
Diluted Earnings Per Share
144.19%
-1.05
-0.43 -0.40 -0.60 -0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.38
price down icon 0.39%
$97.03
price down icon 1.63%
$31.35
price down icon 0.70%
$92.23
price down icon 1.68%
biotechnology ONC
$304.31
price down icon 2.05%
$200.67
price up icon 1.90%
Capitalizzazione:     |  Volume (24 ore):